Case Report Using 4% Fucoidan Cream for Recurrent Oral Herpes Labialis: Patient Symptoms Markedly Improved in Terms of Time to Healing and Time to Loss of Discomfort
DOI:
https://doi.org/10.17140/DOJ-5-135Keywords:
Recurrent oral herpes labialis Vidarabine, Fucoidan, Cream, Clinical trialAbstract
Recurrent oral herpes labialis (ROHL) is a rather widespread oral ulcerative condition with an unclear etiology. The clinical
characteristics of ROHL have been defined and therapies include systemic drugs and topical application of ointment to the lips.
However, these approaches have not been rigorously evaluated. Persistent, painful ROHL was successfully treated with fucoidan
in two patients. This study investigated the time required to complete healing and loss of discomfort. Two patients used Power
Fucoidan CreamTM (PFC) (4% fucoidan cream). ROHL was markedly improved by Power Fucoidan Cream in terms of both
time to healing and time to loss of discomfort. Further clinical trials are needed to confirm the value and safety of topical Power
Fucoidan Cream for treating ROHL.
References
Miyachi M, Imafuku S. Incidence of serum antibody titers against herpes simplex virus in Japanese patients. J Dermatol. 2017; 44(1): 47-51. doi: 10.1111/1346-8138.13506
Patel AR, Romanelli P, Roberts B, Kisner RS. Herpes simplex virus: A histopathologic study of the depth of herpetic wounds. Int J Dermatol. 2009; 48(1): 36-40. doi: 10.1111/j.1365-4632. 2009.03788.x
Kylin H. Biochemistry of seaweeds. Z Physiol Chem. 1918; 101: 236-245. Case Report | Volume 5 | Number 1|
Ribeiro AC, Vieira RP, Mourao PAS, Muloy B. A sulfated alpha-L-fucan from sea cucumber. Carbohydr Res. 1994; 255: 225-240.
Berteau O, Mulloy B. Sulfated fucans, fresh perspectives: Struc-tures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology. 2003; 13(6): 29-40. doi: 10.1093/glycob/cwg058
Siddhanta AK, Murthy ASK. Bioactive polysaccharides from marine brown algae (Phaeophyceae). J Indian Chem Soc. 2001; 78: 431- 437.
Aisa Y. Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol. 2005; 78: 7-14. doi: 10.1002/ ajh.20182
Hidenori T, Mitsuhiko K, Kunihiro K, et al. An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients. Integrative Cancer Thera-pies. 2017; doi: 10.1177/1534735417692097 Submit your article to this journal | https://openventio.org/submit-manuscript/ Case Report | Volume 5 | Number 1| Tsubura S, et al
Japanese patent office. Patent Journal 2010; Patent number 4580123711152.
Francesca Pica and Antonio Volpi. Public Awareness and knowledge of herpes labialis. J Med Virology. 2012; 84: 132-137. doi: 10.1002/jmv.22233
Senni K, Gueniche F, Foucault-Bertaud A, et al. Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. Arch Biochem Biophys. 2016; 445: 56-64. doi: 10.1016/j.abb.2005.11.001
Moon HJ, Lee SH, Ku MJ, Yu BC, Jeon MJ, Jeong SH. Fucoidan inhibits UVB-induced MMP-1 promoter expression and down reg-ulation of type I procollagen synthesis in human skin fibroblasts. Eur J Dermatol. 2009; 19: 129-134. doi: 10.1684/ejd.2008.0611
Fujimura T, Tsukahara K, Moriwaki S, Kitahara T, Sano T, Takema Y. Treatment of human skin with an extract of Fucus ve-siculosus changes its thickness and mechanical properties. J Cosmet Sci. 2002; 53: 1-9.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Dentistry (DOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
